‘Coronavirus: Oxford University vaccine trial paused after participant falls ill’
9 September 2020
11:58
Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had a suspected adverse reaction in the UK.
AstraZeneca described it as a “routine” pause in the case of “an unexplained illness”.
The outcome of vaccine trials is being closely watched around the world.
The AstraZeneca-Oxford University vaccine is seen as a strong contender among dozens being developed globally.
Coronavaccin doorbraak – eerste klinische testresultaten Oxford University vaccin: het lijkt te werken – “responses that we think might be associated with protection”
